"Jan. 3, 2013 -- Is weight loss one of your New Year's resolutions?
If so, you might get some valuable guidance from a new survey of more than 9,000 Consumer Reports readers who have been there, done that.
Phendimetrazine tartrate is indicated in the management of exogenous obesity as a short term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction. The limited usefulness of agents of this class (see Actions) should be measured against possible risk factors inherent in their use such as those described below.
DOSAGE AND ADMINISTRATION
One Slow-Release Capsule (105 mg) in the morning, taken 30-60 minutes before the morning meal.
Phendimetrazine Tartrate is not recommended for use in children under twelve years of age.
Bontril Slow Release Capsules (phendimetrazine tartrate 105 mg) is available as opaque green and clear yellow capsules, imprinted with “VALEANT” and “BONTRIL 105”. Phendimetrazine Slow-Release Capsules are available in bottles of 100 (NDC #0187-0498-01) and 1000 (NDC 0187-0498-02).
Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].
Distributed by: Valeant Pharmaceuticals North America. One Enterprise, Aliso Viejo, CA 92656 USA. Manufactured by: Mallinckrodt Inc. Hobart, NY 13788.
Last reviewed on RxList: 3/26/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Bontril SR Information
Bontril SR - User Reviews
Bontril SR User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.